secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001842952-24-000081
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics stockholders approve doubling authorized shares to 200M
----------------------------------------------------------------------------

- Stockholders voted 42,389,461 for, 790,853 against, 71,655 abstain to increase authorized common shares to 200,000,000.
- Authorization increased from 100,000,000 to 200,000,000 shares of common stock.
- Special Meeting held September 17, 2024; quorum of 43,251,969 shares (57.67%) present.
- Proposal also included approval of adjournments if needed, passed with 42,447,035 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295224000081/0001842952-24-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295224000081/cntx-20240917.htm
  HTML page:      https://secwatch.observer/filing/0001842952-24-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer